arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

GH Research PLC

GHRS Health Care Biotechnology: Pharmaceutical Preparations
$28.77
▲ +1.9% Today
as of Sep 4, 16:49 ET
Last 30 days +1.73% Jul 27 → Sep 04
$26.69 $27.75 $28.81 $29.87 $30.93 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$28.16
High
$28.31
Low
$27.26
Volume
$78,097
Avg Vol
$301,619
Mkt Cap
$1.9B
P/E (TTM)
—
Beta
—
52w High
$31.44
52w Low
$11.83
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 3 items

Aug 2 · 18:09 Simply Wall St.
Is GH Research (GHRS) Trading At A Premium To Fair Value?
Jul 27 · 14:38 Stocktwits
CMPS, MDGL, DFTX, GHRS, HELP Stocks In Spotlight Today – Why Wells Fargo Thinks Next Wave Of Depression Drugs Could Create New Winners
Jul 16 · 10:33 InvestorsHub
GH Research gains on optimism surrounding potential Eli Lilly-Atai deal (GHRS)

Overview

52-week range
$12
$31
86% of range
Avg surprise (last 3)
+28.6%
Avg reaction (last 2)
+3.3%
100% positive
Latest IV / EM
118%
EM ±18.4% · $30 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.61$-0.49$-0.38$-0.27$-0.15 Actual $-0.19Est $-0.61Actual $-0.15Est $-0.22Actual $-0.31Est $-0.27 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-0.31 $-0.27 -14.8% -63.2% +1.5% earnings
Thu Aug 7, 2025Jun/2025 $-0.15 $-0.22 +31.8% — — earnings
Thu May 8, 2025Mar/2025 $-0.19 $-0.61 +68.8% — +5.2% earnings

Implied volatility — last 90 days

42%131%221%310%399% Jun 08 — IV 203% · EM ±26.8%Jun 09 — IV 227% · EM ±28.5%Jun 10 — IV 212% · EM ±25.0%Jun 11 — IV 237% · EM ±26.1%Jun 12 — IV 245% · EM ±25.1%Jun 15 — IV 139% · EM ±10.1%Jun 19 — IV 102% · EM ±22.5%Jun 22 — IV 111% · EM ±23.2%Jun 23 — IV 120% · EM ±24.6%Jun 24 — IV 88% · EM ±17.7%Jun 25 — IV 90% · EM ±17.6%Jun 26 — IV 116% · EM ±22.3%Jun 29 — IV 123% · EM ±21.8%Jun 30 — IV 112% · EM ±19.3%Jul 01 — IV 123% · EM ±20.6%Jul 02 — IV 131% · EM ±21.2%Jul 03 — IV 137% · EM ±21.5%Jul 07 — IV 99% · EM ±13.1%Jul 08 — IV 155% · EM ±19.4%Jul 09 — IV 177% · EM ±21.0%Jul 16 — IV 399% · EM ±16.7%Jul 20 — IV 114% · EM ±26.9%Jul 21 — IV 86% · EM ±19.9%Jul 22 — IV 81% · EM ±18.5%Jul 23 — IV 71% · EM ±15.9%Jul 24 — IV 73% · EM ±16.0%Jul 27 — IV 74% · EM ±15.5%Jul 28 — IV 131% · EM ±26.8%Jul 29 — IV 116% · EM ±23.2%Jul 30 — IV 77% · EM ±15.1%Jul 31 — IV 71% · EM ±13.6%Aug 03 — IV 128% · EM ±22.7%Aug 04 — IV 79% · EM ±13.6%Aug 05 — IV 77% · EM ±12.9%Aug 06 — IV 59% · EM ±9.5%Aug 10 — IV 93% · EM ±12.9%Aug 11 — IV 117% · EM ±15.5%Aug 12 — IV 136% · EM ±17.0%Aug 14 — IV 43% · EM ±4.7%Aug 17 — IV 170% · EM ±14.2%Aug 18 — IV 153% · EM ±11.1%Aug 20 — IV 221% · EM ±9.2%Aug 24 — IV 103% · EM ±21.4%Aug 25 — IV 60% · EM ±12.3%Aug 26 — IV 79% · EM ±15.9%Aug 27 — IV 78% · EM ±15.4%Aug 28 — IV 101% · EM ±19.3%Aug 31 — IV 75% · EM ±13.3%Sep 01 — IV 138% · EM ±23.8%Sep 02 — IV 116% · EM ±19.3%Sep 03 — IV 120% · EM ±19.3%Sep 04 — IV 118% · EM ±18.4%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in